Catalyst Biosciences Inc logo

Catalyst Biosciences Inc

$ 0.51 -0.0054 (-1.04%) 10:51 AM EST
P/E:
At Loss
P/B:
0.20
Market Cap:
$ 16.21M
Enterprise V:
$ -57.45M
Volume:
105.44K
Avg Vol (2M):
812.33K
Also Trade In:
Volume:
105.44K
Market Cap $:
16.21M
PE Ratio:
At Loss
Avg Vol (2-Month):
812.33K
Enterprise Value $:
-57.45M
PB Ratio:
0.20
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. It mainly focuses on developing novel medicines to address serious medical conditions for individuals in need of treatment options. The company emphasizes product development efforts in the field of hemostasis and to develop valuable therapies for individuals with hemophilia. It is engaged in the clinical development of improved, next-generation subcutaneous prophylaxis using enhanced potency Factor VIIa and Factor IX variants.
Name Current Vs Industry Vs History
Cash-To-Debt 53.28
Equity-to-Asset 0.95
Debt-to-Equity 0.02
Debt-to-EBITDA -0.02
Interest Coverage No Debt
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.02
Distress
Grey
Safe
Beneish M-Score -1.14
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 13.92
9-Day RSI 10.88
14-Day RSI 12.8
6-1 Month Momentum % 191.04
12-1 Month Momentum % -49.22

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 18.86
Quick Ratio 18.86
Cash Ratio 17.49
Days Sales Outstanding 138.1
Days Payable 234.51

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -38

Financials (Next Earnings Date:2022-11-11 Est.)

CBIO's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CBIO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 5.533
EPS (TTM) ($) -0.26
Beta 0.81
Volatility % 193.42
14-Day RSI 12.8
14-Day ATR ($) 0.099666
20-Day SMA ($) 1.228545
12-1 Month Momentum % -49.22
52-Week Range ($) 0.3501 - 4.21
Shares Outstanding (Mil) 31.48

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Catalyst Biosciences Inc Filings

Document Form Filing Date
No Filing Data

Catalyst Biosciences Inc Analysis

Share your research

Headlines

See More
No news.